Group 1 - Hinge Health, Inc. (NYSE:HNGE) reported Q3 revenue of $154.2 million, a 53% year-over-year increase, exceeding consensus estimates by approximately $12 million [1][2] - The company achieved a non-GAAP operating income of $30.4 million and a non-GAAP gross margin of 83% [1] - Piper Sandler raised its target price for Hinge Health to $71, indicating an Overweight rating, based on strong performance and improved yield [1][2] Group 2 - For Q4, Hinge Health guided revenue to be between $155 million and $157 million, surpassing the Street's estimate of around $145.5 million [2] - The company also raised its 2025 revenue outlook to a range of $572 million to $574 million, compared to the consensus of approximately $550.6 million [2] - Hinge Health operates as a musculoskeletal digital clinic, providing personalized physical therapy and pain management through wearable sensors and app-based coaching [3]